Omega Healthcare Investors Inc OHI
Institutional shares held
184 Million
1.73M
calls
1M
puts
Total value of holdings
$6.96B
$65.3M
calls
$37.9M
puts
Market Cap
$8.86B
234,111,008
Shares Out.
Institutional ownership
78.6%
# of Institutions
660
We take great care to ensure that the data presented and summarized in this overview for OMEGA HEALTHCARE INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OHI
View all-
Vanguard Group Inc Valley Forge, PA36.3MShares$1.37 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY30.1MShares$1.14 Billion0.02% of portfolio
-
Cohen & Steers, Inc. New York, NY17.4MShares$658 Million1.26% of portfolio
-
State Street Corp Boston, MA12.3MShares$467 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA6.43MShares$243 Million0.02% of portfolio
-
Daiwa Securities Group Inc. Tokyo, M03.95MShares$149 Million0.74% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA3.83MShares$145 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.78MShares$143 Million0.04% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA3.02MShares$114 Million1.19% of portfolio
-
Bank Of America Corp Charlotte, NC2.82MShares$107 Million0.01% of portfolio
Latest Institutional Activity in OHI
Top Purchases
Top Sells
About OHI
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Insider Transactions at OHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
19
-0.55%
|
$760
$40.7 P/Share
|
|
Oct 01
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
215
+5.85%
|
$8,600
$40.7 P/Share
|
|
Sep 27
2024
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
56,725
-36.19%
|
$2,269,000
$40.25 P/Share
|
|
Sep 27
2024
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
22,542
-10.96%
|
$901,680
$40.19 P/Share
|
|
Sep 05
2024
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-13.76%
|
$1,000,000
$40.06 P/Share
|
|
Aug 26
2024
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-12.73%
|
$1,140,000
$38.78 P/Share
|
|
Aug 23
2024
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-12.09%
|
$950,000
$38.71 P/Share
|
|
Aug 13
2024
|
Lisa Egbuonu Davis |
SELL
Open market or private sale
|
Direct |
1,352
-7.46%
|
$51,376
$38.0 P/Share
|
|
Jul 01
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16
-0.49%
|
$544
$34.25 P/Share
|
|
Jul 01
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
232
+6.64%
|
$6,032
$26.92 P/Share
|
|
Jun 21
2024
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
1,850
-0.78%
|
-
|
|
Jun 07
2024
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
4,605
+10.38%
|
$147,360
$32.57 P/Share
|
|
Jun 07
2024
|
Lisa Egbuonu Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,605
+20.27%
|
$147,360
$32.57 P/Share
|
|
Jun 07
2024
|
Kevin J Jacobs |
BUY
Grant, award, or other acquisition
|
Direct |
7,522
+18.25%
|
$240,704
$32.57 P/Share
|
|
Mar 31
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13
-0.43%
|
$403
$31.67 P/Share
|
|
Mar 31
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
240
+7.31%
|
$6,240
$26.07 P/Share
|
|
Jan 02
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13
-0.46%
|
$390
$30.66 P/Share
|
|
Jan 02
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
239
+7.82%
|
$6,214
$26.07 P/Share
|
|
Dec 31
2023
|
Gail D Makode CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
142
+11.06%
|
-
|
|
Dec 31
2023
|
Daniel J Booth CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,712
-4.93%
|
$321,360
$30.66 P/Share
|
Last 12 Months Summary
Buy / Acquisition
39.9K
Shares
From
6
Insiders
| Grant, award, or other acquisition | 17.8K shares |
|---|---|
| Exercise of conversion of derivative security | 22.1K shares |
Sell / Disposition
173K
Shares
From
6
Insiders
| Payment of exercise price or tax liability | 10.8K shares |
|---|---|
| Open market or private sale | 161K shares |
| Bona fide gift | 1.85K shares |